MitoRx Publishes Study on AP39’s Effectiveness in Reducing Obesity
MitoRx Therapeutics has published a study in Pharmacological Research demonstrating that its mitochondrial-targeted sulfide-donor compound, AP39, significantly reduces weight gain and fatty liver. This study is the first to explore the potential of mitochondrial sulfide donors in addressing obesity-related disorders.
More
New Quantum Cluster aims to create 1,000 high-value jobs and attract £1 billion investment over next decade
The UK’s new Harwell Quantum Cluster officially launched yesterday at the Harwell Science and Innovation Campus, marking a pivotal step in the nation’s ambition to lead the global quantum revolution. The cluster will accelerate quantum innovation, scale emerging technologies, and aim to create over 1,000 high-value jobs and £1 billion […]
Exciting News for Oxfordshire’s Science Community!
The Crown Estate has acquired a 221-acre site next to the Harwell Science and Innovation Campus, aiming to create a world-class science and technology hub. The £4.5 billion development, known as Harwell East, could deliver up to 4.5 million sq ft of lab and office space, 400 homes, and generate […]
Harwell Science and Innovation Campus Celebrates 80 Years of Discovery with Bold Expansion Plans
Harwell Campus, the UK’s leading science and innovation hub, is marking its 80th anniversary with ambitious growth plans. Already home to the nation’s largest concentration of research facilities, Harwell has delivered 1 million SQF of new space since 2020 and is set to add another 4 million SQF to support […]
